Go Pro
NASDAQ:SLSN

Solesence Q3 2025 Earnings Report

Solesence logo
$0.80 -0.02 (-2.35%)
Closing price 09/18/2026 04:00 PM Eastern
Extended Trading
$0.82 +0.02 (+2.66%)
As of 09/18/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Solesence EPS Results

Actual EPS
-$0.02
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Solesence Revenue Results

Actual Revenue
$14.60 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Solesence Announcement Details

Quarter
Q3 2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Solesence Earnings Headlines

Solesence, Inc. Charts Rebound Amid Mixed Earnings
Solesence, Inc. (SLSN) Q2 2026 Earnings Call Transcript
Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.tc pixel
Solésence Reports Second Quarter 2026 Financial Results
See More Solesence Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Solesence? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Solesence and other key companies, straight to your email.

About Solesence

Solesence (NASDAQ:SLSN) is a skincare company focused on developing and commercializing science-based products designed to improve the health and appearance of skin. The company combines dermatological research, cosmetic formulation and biotechnology to create products intended to address concerns such as sun damage, uneven skin tone, visible signs of aging and other common skin conditions.

Its portfolio includes topical skincare and sun-protection products formulated for daily use and professional skincare routines. Solesence develops products for physician, dermatology, aesthetic and consumer channels, with an emphasis on clinically informed formulations and skin-health benefits.

The company works with skincare professionals and commercial partners to bring its products to market. Publicly available information about Solesence’s leadership, operating history and geographic reach is limited.

View Solesence Profile